Corneal neovascularization

Exp Eye Res. 2021 Jan:202:108363. doi: 10.1016/j.exer.2020.108363. Epub 2020 Nov 19.

Abstract

The optical clarity of the cornea is essential for maintaining good visual acuity. Corneal neovascularization, which is a major cause of vision loss worldwide, leads to corneal opacification and often contributes to a cycle of chronic inflammation. While numerous factors prevent angiogenesis within the cornea, infection, inflammation, hypoxia, trauma, corneal degeneration, and corneal transplantation can all disrupt these homeostatic safeguards to promote neovascularization. Here, we summarize its etiopathogenesis and discuss the molecular biology of angiogenesis within the cornea. We then review the clinical assessment and diagnostic evaluation of corneal neovascularization. Finally, we describe current and emerging therapies.

Keywords: Angiogenesis; Corneal neovascularization; Vascular endothelial growth factor (VEGF).

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Cornea / diagnostic imaging*
  • Corneal Neovascularization / diagnosis*
  • Corneal Neovascularization / drug therapy
  • Diagnostic Imaging / methods*
  • Humans
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A